bg
S

Sage Therapeutics (SAGE)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Sage Therapeutics (SAGE)

SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company's lead product candidate, SAGE-547 is an intravenou... Read more

  • USD9.12
  • USD9.22
  • USD9.11
  • USD13.47
  • 40.90%
  • 47M
  • 3.01M
  • 2.22M
  • 573M
  • 4.62
  • -13.40%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.